Nexus Medical Labs will implement Lybe Scientific’s NAxtra nucleic acid extraction kit in a 60,000-plus test unit deal to enhance high-throughput STI testing, citing improved detection limits and workflow efficiency.
OraSure Technologies announced FDA approval for expanding the age range of its OraQuick HIV Self-Test to individuals aged 14 and older.
The NIAID has awarded grants for 10 projects aimed at developing advanced diagnostic tools for congenital and adult syphilis.
A study highlights significant gaps in adherence to guideline-based testing and treatment for chlamydia and gonorrhea for pregnant women.
Read More
A study by FAIR Health reveals a 4.8 percent increase in STD diagnoses among commercially insured patients from 2020 to 2023.
Read More
Researchers developed a new lab test to detect intact HIV infections with African strains, crucial for advancing global HIV cure efforts.
Read More
Syphilis cases are rising globally, yet many Americans remain unaware of its symptoms and treatment options.
Read More
There has been significant rise in sexually transmitted infections (STIs), underscoring the need for improved STI testing and diagnostics.
Read More
Syphilis cases in Tennessee have surged among women, due to insufficient prenatal testing and treatment, compounded by a penicillin shortage.
Read More
Testmate Health secured $6 million in seed funding to develop an OTC self-test for STIs, initially targeting chlamydia and gonorrhea.
Read More
Scout received funding to develop a test to detect and differentiate between Neisseria gonorrhoeae and Chlamydia trachomatis quickly.
Read More
To increase the amount of syphilis testing, labs need to remove moral judgement and acknowledge the STI as just another infection.
Read More
To stem the tide of the STI epidemic, health care must work together through education, prevention, screening, diagnosis, and treatment.
Read More
Thee American Medical Association launched a new toolkit to help increase screenings for HIV, STIs, viral hepatitis and latent tuberculosis.
Read More
Emphasizing the healthcare disparities through increased testing for effective prevention of congenital syphilis needs addressing.
Read More
NOWDiagnostics submitted a De Novo Classification Request to the U.S. FDA for the company’s First to Know at-home syphilis test.
Read More
The FDA is providing this information to educate health care providers and clinical laboratory staff and reduce the risk of false results.
Read More
The company began commercial shipments as part of the initial purchase order for 2.5 million tests, with further shipments scheduled.
Read More